Kalaris Therapeutics Inc (KLRS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.77
    1.96%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Kalaris Therapeutics Inc Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022
    Period Ending Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -14.7M -15.48M
    Depreciation & Amortization
    		 n/a n/a
    Stock-Based Compensation
    		 148K 271K
    Other Working Capital
    		 -690K 1.57M
    Other Non-Cash Items
    		 1.51M 2.04M
    Deferred Income Tax
    		 n/a n/a
    Change in Working Capital
    		 -1.09M 3.4M
    Operating Cash Flow
    		 -14.13M -9.78M
    Capital Expenditures
    		 n/a n/a
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 n/a n/a
    Debt Repayment
    		 6M 4.3M
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 1.5M 5K
    Financial Cash Flow
    		 14.24M 12.78M
    Net Cash Flow
    		 110K 3M
    Free Cash Flow
    		 -14.13M -9.78M

    Add to Watchlist